What CRUSH Would Change for Medicare Advantage Plans
The HHS announcement describes the Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) proposed rule as a way to save taxpayers nearly $90 billion over 10 years across Medicare, Medicaid, CHIP and the ACA marketplace. For Medicare Advantage (MA) insurers, the key provisions are:
Haven't Insurers Already Fought This in Court?
Partly. Becker's notes that Humana sued over CMS's 2023 RADV rule, a federal judge in Texas vacated it in September 2025, and HHS appealed. Per Becker's, CRUSH would effectively re-propose elements of the vacated rule by extrapolating audit findings back to 2018, without applying the fee-for-service adjuster the industry had argued for. It's a proposal, not a final rule, so comments, revisions and further litigation are all possible.
Mizuho Ranks Humana and UnitedHealth Most Exposed
Mizuho analyst Ann Hynes called the proposal an incremental negative for MA margins, per The Fly via TipRanks. She sees Humana and UnitedHealth as most affected given their MA exposure, followed by CVS Health, Elevance Health, Centene and Molina. The broader market was also falling ahead of Nvidia's earnings, which added to the pressure (Investing.com).
| Stock | Monday close | Session low | Late morning (Cboe, delayed) | IV30 |
A Rule That Takes Years Doesn't Move Weekly IV Much
A proposed rule plays out over months or years: a comment period, a final rule, possible lawsuits and an effective date. That's one reason short-dated implied volatility stayed modest even as shares fell. Using midpoints of Cboe's late-morning quotes, Nov 20 at-the-money straddles priced:
UNH and HUM have already fallen about as far today as their weeklies price for the rest of the week.
UnitedHealth Call Buyers Reached Out to January
UNH flow leaned to calls, about 15,500 calls vs. 9,100 puts. The busiest line was the Jan 15, 2027 $450 call (about 1,400 contracts, open interest about 7,900), followed by the Nov 20 $420 call (about 1,300). On the downside, the Nov 20 $377.50 put traded about 990 contracts against open interest of about 730, which points to new positions. In CVS, the Feb 19, 2027 $92.50 calls traded about 1,370 contracts, more than six times their open interest. Humana's options were thin and wide. Volume alone doesn't show whether contracts were bought or sold.
Headline Risk Doesn't End With the Proposal
For background, see our implied volatility explainer and the OCC options disclosure document.
Sources
*By the OptionsPilot Editorial Team. Published November 17, 2026, 8:35 AM PT. Market data are 15-minute-delayed Cboe quotes from late Tuesday morning and will change. This article is for education only and is not investment advice. Options involve risk and are not suitable for all investors.*